Name: Assessing Nanoparticle Risks to Human Health (Micro and Nano Technologies) (en Inglés)
Price: 146470.00 CLP
Availability: InStock
Author: Gurumurthy Ramachandran
ISBN: 9780128103692

portada Assessing Nanoparticle Risks to Human Health (Micro and Nano Technologies) (en Inglés)

Formato

Libro Físico

Editorial

William Andrew

Autor

Gurumurthy Ramachandran

Año

2016

Idioma

Inglés

N° páginas

297

Encuadernación

Tapa Blanda

ISBN13

9780128103692

N° edición

Categorías

Ciencia, ingeniería y tecnología medioambientales

Assessing Nanoparticle Risks to Human Health (Micro and Nano Technologies) (en Inglés)

Gurumurthy Ramachandran (Autor) · William Andrew · Tapa Blanda

Libro Físico

$ 146.470

$ 244.120

Ahorras: $ 97.650

40% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Miércoles 29 de Mayo y el Lunes 10 de Junio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Assessing Nanoparticle Risks to Human Health (Micro and Nano Technologies) (en Inglés)"

The book will take a systematic look at nanoparticle risks within the paradigm of risk assessment, consider the limitations of this paradigm in dealing with the extreme uncertainties regarding many aspects of nanoparticle exposure and toxicity, and suggest new methods for assessing and managing risks in this context. It will consider the occupational environment where the potential for human exposure is the greatest as well as the issues relevant to occupational exposure assessment (e.g., the exposure metric) and the evidence from toxicological and epidemiological studies. A chapter will be devoted to how conventional risk assessment can be carried out for a candidate nanoparticle (e.g., carbon nanotubes), and the limitations that arise from this approach. We will propose several alternate methods in another chapter including screening assessments and adapting the rich methodological literature on the use of experts for risk assessment. Another chapter will deal with non-occupational populations, their susceptibilities, and life-cycle risk assessments. There will be a chapter on current risk management and regulatory oversight frameworks and their adequacy. This chapter will also include a discussion of U.S. and E.U. approaches to risk assessment, as well as corporate approaches.